|
|
|
Jim Barlow
Global Market Research Point - Ridaforolimus
Merck Oncology
Jim has been with Merck since 2005. He joined the company in the MBA marketing leadership program (MMA program) and is completing his
Market Research rotation in oncology, as the second stage of the program. During the first stage, Jim completed a rotation in Sales, where he
was involved with sales of Zocor®, Fosamax®, Singulair® and the launch of Januvia®. Jim is currently the global market research point for
ridaforolimus and is focused on completing market research to inform the global launch strategy of the brand. Jim has a BA in Mathematical
Economics from Colgate University and an MBA in Strategy and Marketing from Carnegie Mellon’s Tepper School of Business.
_______________________________________________________________________________________________________________
|
|
|
|
David Berman
Sr. Director, Global Customer Insights
Merck
David Berman is a professional market researcher with over 25 years experience in the pharmaceutical industry.
David is currently responsible for leading 3 teams at Merck, the ID franchise team, the Cross-Divisional team, and the Market Research
Excellence team, all part of the Global Customer Insights department. David has been employed at Merck for the past 18 months.
Prior to joining Merck, David spent 3 years at J&J as Director of Market Research for Virology products. For 10 years before this David owned
and operated The Mercury Group, a qualitative market research company focusing on the pharmaceutical industry. David has also worked at
Sanofi as well as Bristol Myers Squibb. His experiences span across a range of disciplines, having worked in R&D, Clinical Research,
Marketing, Market Research, New Business Development as well as International Management.
David received a BA degree in Microbiology and an MBA in Pharmaceutical Management.
_______________________________________________________________________________________________________________
|
|
|
|
Stan Bernard
President
Bernard Associates, LLC
Stan Bernard, MD, MBA is the Founder and President of Bernard Associates (www.BernardAssociatesLLC.com), a pharmaceutical and health
care industry management consulting firm that offers strategic planning, marketing, competitive simulations (war games), competitive
planning, and business development services. The firm thrives on the cutting-edge: new products, technologies, services, ventures, markets,
customer segments, opportunities, challenges, and issues. Bernard Associates has worked with nine of the top ten pharmaceutical
companies and many of the leading biopharmaceutical, medical device, diagnostics, and health care products companies.
Dr. Bernard is nationally recognized as a health care and pharmaceutical industry consultant, speaker, and author. He has been featured on
national television and in leading publications, including the Wall Street Journal, Business 2.0, and Business Week. He has published over 50
book chapters and articles on health care and pharmaceutical topics.
Previously, Dr. Bernard served as a Principal in the Health Care and Pharmaceutical Industry Consulting Practice at A.T. Kearney. Prior to
joining A.T. Kearney, Dr. Bernard worked at Bristol-Myers Squibb Pharmaceutical Company where he held several executive business and
medical positions. He served as U.S. Product Manager for the launch of the cholesterol-lowering drug Pravachol, Bristol-Myers Squibb’s most
successful pharmaceutical product. He served as U.S. Managed Care Medical Director, the first person to hold such a position in the
pharmaceutical industry, and as U.S. Director - Pharmacoeconomics. Previous positions included those in Worldwide Business Development,
U.S. Medical Operations, and U.S. Medical Services.
Dr. Bernard is a former Senior Fellow in the Health Care Systems Department at The Wharton School of Business where he initiated and
taught in the “Pharmaceutical Management” course for fourteen years. Dr. Bernard is the recipient of the prestigious Wharton School of
Business Alumni Achievement Award for his contributions to Wharton and the health care industry. Dr. Bernard received his M.B.A. in marketing
and health care management from the Wharton School of Business. He received his Medical Degree from Baylor College of Medicine.
_______________________________________________________________________________________________________________
|
|
|
|
Chris Bogan
CEO
Best Practices
Chris Bogan is the Chief Executive Officer and Founder of Best Practices®, LLC, a leader in the field of best practice performance
improvement. Based in Chapel Hill, North Carolina, Best Practices®, LLC specializes in providing pharmaceutical, biotechnology and medical
device corporations throughout the world with business intelligence, research, benchmarking studies, and consulting services. The company's
products and services provide corporations with "Access And Intelligence For Achieving World-Class Excellence™."
Mr. Bogan received his MBA with honors from the Harvard Business School and his bachelor's degree magna cum laude from Amherst
College. He was a Nieman Fellow at Harvard University. Mr. Bogan's work has focused on organizational excellence, blockbuster product
launches, marketing excellence, sales force effectiveness, clinical operations and best practice improvement strategies. He has written about
numerous aspects of performance excellence and continuous improvement. In recent years, he has concentrated on ways that companies can
use best practice insights to create economic value, accelerate revenue and profit growth, and drive rapid performance improvement. He is co-
author of the widely acclaimed books, Benchmarking For Best Practices: Winning Through Innovative Adaptation, published by McGraw-Hill,
and The Baldrige: What It Is, How It's Won, and How To Use It To Improve Quality In Your Company.
Mr. Bogan has consulted on performance improvement and best practice competitiveness issues for a wide range of pharmaceutical,
biotechnology and medical device companies, including Pfizer, Eli Lilly, GlaxoSmithKline, Genentech, J&J, Amylin, Sanofi-Aventis, AstraZeneca,
Amgen, Novartis, Roche, Baxter Healthcare, Bayer, 3M Pharmaceuticals, Abbott Laboratories, Astellas, LifeScan, Guidant, Janssen
Pharmaceutica and others.
Mr. Bogan led the consulting teams that assisted both Federal Express and GTE Directories (now Verizon) in winning the prestigious Malcolm
Baldrige National Quality Award. He has also advised many leading corporations outside the healthcare sector, including industry leaders
such as Microsoft, American Express, AT&T, General Motors, BellSouth, Chevron, Exxon, Xerox, Verizon, Marriott, Merrill Lynch, Siemens, KPMG,
the New York Times Company, J.P. Morgan Chase & Co., TIAACREF, Nortel Networks, Pitney Bowes, Bank of America, Wachovia and many
others.
A guest lecturer at Northwestern University’s Kellogg School of Management and the University of North Carolina’s (UNC) Kenan Flagler
Business School, Mr. Bogan has spoken widely before business audiences in North America, Europe, Asia and Latin America. He is an
advisor to various management magazines on best practice and management issues. He currently serves on the UNC Academic Leadership
Institute’s National Advisory Board. Previously, he served on the Board of Directors of Ontogeny, Inc., a stem cell and functional genomics
company now named Curis, Inc.
Prior to founding Best Practices, LLC, Mr. Bogan was a principal and founding member of The TQM Group, Ltd., a Bostonbased consultancy.
Mr. Bogan also spent many years working at various media companies, including Times Mirror Corp., Knight-Ridder Inc., Howard Publications
and Cowles Publishing Co. He has contributed articles to many newspapers and magazines, including The Harvard Business Review, Time,
Pharmaceutical Executive, PharmaVoice, MedAd News, Planning Review, The Los Angeles Times, The Boston Globe, The Miami Herald, The
Chicago Tribune and The Philadelphia Inquirer. Through his work, Mr. Bogan has toured manufacturing and service companies throughout
the world.
_______________________________________________________________________________________________________________
|
|
|
|
Branimir Brankov, M.D., M.B.A.
Sr. Director Strategic Business Intelligence
Merck & Co., Inc.
Dr. Branimir Brankov is a professional manager and marketer with a medical and business background and more than 15 years experience in
the pharmaceutical industry.
Dr. Brankov is currently responsible for Strategic Business Intelligence Group which is part of the Global Competitive Intelligence Unit
established in the Merck Headquarter in Whitehouse Station, N.J., U.S.A. In this capacity, his main functions include managing global projects
and initiatives, conducting competitive analysis and providing guidance to Merck Executives and Global Marketing Teams on strategy
development.
In his previous roles at Merck, Dr. Brankov has been Global Leader for Physician Communities of Practice initiative at Merck. As part of the
Global market research team in Merck Headquarter he has been responsible for providing global market research and business intelligence
support for several therapeutic areas. Before his assignments in Merck Headquarter Dr. Brankov was responsible for establishing and
managing independent subsidiaries for Merck & Co., Inc. in Bulgaria, Macedonia and Albania.
Dr. Brankov received his M.D. from the Medical University of Sofia and practiced at the Military Medical Academy in Sofia, Bulgaria, specializing
in Neurosurgery. In 2001, he obtained a Masters’ Degree in Economics from the Economics University of Sofia, with concentration in Human
Resources; and, in 2003, he earned a Masters’ Degree in Business Administration from Rutgers University, New Jersey, with concentration in
Marketing and Management. He is active member of PBIRG, SCIP and MRII.
_______________________________________________________________________________________________________________
|
|
|
|
Julie Clemens
VP, Client Consulting
Nielsen
Julie Clemens is a Vice President in the Pharmaceutical Practice of Nielsen BASES. Nielsen BASES is a validated system for forecasting
product innovation by combining key stakeholders’ evaluation of the product concept, proposed marketing strategies, and insights from
experienced forecasters and consultants. Nielsen BASES’ mission is to help companies grow through successful innovation.
Julie has been a forecasting leader in many areas since joining the company in 1996. With an analytic background in OTC healthcare, she
helped establish Nielsen BASES’ initial services for DTC evaluations in the late 90's. She then spent five years in Europe building BASES
services globally before re-joining the healthcare sector in 2005. Today Julie consults with her pharmaceutical clients on a variety of business
issues including new product launches, clinical trial optimization, lifecycle management, and DTC returns on investment.
_______________________________________________________________________________________________________________
|
| |
|
Ajaya Das
Associate Director, Market Research
Bristol Myers Squibb Co
_______________________________________________________________________________________________________________
|
|
|
|
Donna DiStefano
Senior Manager, Global Market Intelligence
Alcon Laboratories
Donna DiStefano is Senior Manager of Global Market Intelligence at Alcon Laboratories. In this role she is manages all market intelligence
activities for the Global Glaucoma Franchise iincluding both pharmaceutical and surgical glaucoma products. Her responsibilities include all
aspects of market research, both primary and secondary data.
Prior to joining Alcon Laboratories, Donna spent more than a decade on the supplier side of the pharmaceutical market research industry and
has a breadth of experience and expertise in methodologies and approaches. Throughout her career she has been particularly focused on
issues related to chronic disease.
Donna has a BS and an MPH.
_______________________________________________________________________________________________________________
|
|
|
|
Sandipa Dublish
Director Global Market Research
Eisai
Sandipa Dublish is Director, Global Market Research at Eisai Corp. In this role she manages all aspects of strategic business insights
including Global Forecasts for New Products. In her previous position as Director, Oncology Market Research with Bristol-Myers Squibb –
Sandipa developed global forecasts for new oncology drugs.
Sandipa understands both the science and art of forecasting, and the challenges involved in making sound assumptions. She firmly believes
that successful forecasts require participation from different stakeholders within the organization, and is currently developing a Global Forecast
process for her organization.
Sandipa holds a PhD. in Marketing from Florida International University and an MBA from Faculty of Management Studies, Delhi, India.
._______________________________________________________________________________________________________________
|
|
|
|
Tim Edbrooke
Chief Business Officer
Healogix
Tim’s pharmaceutical career spans 20 years and an impressive array of disciplines from clinical development through to the
commercialization of products and general management. At Healogix he is responsible for developing and implementing all aspects of our
client engagement process, ensuring that we create highly effective partnerships with our clients that help drive their businesses forward.
Tim’s experience of working on both the client and services side of the industry affords him an excellent understanding of what clients require
and an appreciation of how to make it happen.
Tim is also a lead contributor to the ongoing development of additional service offerings which we design to meet our client’s business needs
in the increasingly challenging environment.
Tim was most recently the Chief Executive Officer at Genactis, Inc., a research based consultancy specializing in the Pharmaceutical and
Biotechnology industry. Prior to that he held executive leadership roles at TVG Inc. as well as GfK Healthcare (formerly NOP World Health) with
responsibility for global business development and marketing activities. Tim started his career in the UK on the client side at Merck and later
moved to Organon Teknika where he assumed full P&L responsibilities for the Pharmaceutical Division.
_______________________________________________________________________________________________________________
|
|
|
|
Mark Edelstein
Senior Director Market Research
Lundbeck
Mark Edelstein has been an active champion for the Marketing Research function for nearly 25 years, committed to, and passionate about
raising the standards, excellence and impact of this remarkable function. Most recently, Mark joined Lundbeck Inc., in the Chicago metro area,
as Senior Director of Marketing Research for the new U.S. arm of this Copenhagen-based pharmaceutical company. Prior to joining
Lundbeck, Mark spent nearly 9 years as a global pharmaceutical marketing research consultant. From 2008-2009, he was Vice President,
Marketing Research for the new U.S. subsidiary of the Planning Shop international – a UK based pharmaceutical marketing research
consultancy. In 2001, Mark founded his own company, Mark Edelstein Consulting, Inc., where he served as President and lead consultant to
the global healthcare industry, focusing on cultivating Marketing Research and Business Intelligence. Prior to starting up his own consulting
firm, he spent 15 years on the healthcare manufacturer ("client") side, working for such Pharmaceutical leaders as Pharmacia, Abbott
Laboratories, Searle (Monsanto), and Merck & Co. Over that time, Mark was the lead market researcher driving the development and launches
of some of the industry’s most successful products, including Prilosec™, Biaxin™, Depakote™, and Celebrex™. Under his leadership,
Marketing Research has brought marketing insight and perspective to guide many other products in pre-clinical, launch and mature life-cycle
stages.
Currently, Mr. Edelstein is serving as a mentor-coach for students enrolled in a new online certification program for marketing researchers
worldwide: Principles of Pharmaceutical Marketing Research – sponsored by the University of Georgia. He is very excited to be a part of this
revolutionary new course, and excited to work together with new colleagues from around the globe.
Mark began his professional career as a practicing Chemical Engineer for nearly 10 years, crediting his experiences at FMC and Procter &
Gamble with teaching him the art and skill of problem solving, project management, and the critical importance of collaborative work
relationships. He holds a Bachelor’s Degree in Chemical Engineering from Lehigh University in Bethlehem, Pennsylvania, and a Master’s
Degree in Marketing from Drexel University, Philadelphia, Pennsylvania.
_______________________________________________________________________________________________________________
|
|
|
|
Kendall Gay
Senior Consultant
KGC
Kendall is a 19-year professional marketing researcher, all of which have been in healthcare. He now practices qualitative marketing research
exclusively. Kendall started his career with an entry-level position at Spiller & Reeves research and has performed every function in a marketing
research company from analyst to owner.
After climbing to a position as Vice President at Spiller & Reeves, Kendall decided to venture out on his own. He founded Kendall Gay
Consulting, Inc. (KGC) on October 1, 1997.
Kendall has conducted literally thousands of focus groups and interviews face-to-face, over the phone and on the Internet. Patients, doctors,
nurses, ancillary health care professionals, and health care executives are just some of the respondent populations he has worked with.
Kendall has extensive experience in pharmaceuticals, medical devices and healthcare communications, from launch to re-positioning,
licensing & acquisition to employee issues.
Kendall graduated cum laude from the University of South Florida in 1990 with a BA in Advertising and a concentration in psychology. He is a
member of the Qualitative Research Consultants Association (QRCA), the American Marketing Association (AMA), the Pharmaceutical
Marketing Research Group (PMRG), the Association of Qualitative Research, and the Pharmaceutical Business Intelligence and Research
Group (PBIRG).
Mr. Gay regularly speaks on the subject of healthcare qualitative research by presenting case studies, methodologies, and techniques.
Kendall has presented at meetings of the PMRG and QRCA in the United States as well as presentations at meetings of the Worldwide
Conference on Qualitative Research in Lisbon and Barcelona.
_______________________________________________________________________________________________________________
|
| |
|
Stuart Greenberg
Deputy Director, Global/Oncology Market Research
Bayer
Dr. Stuart E. Greenberg is currently Deputy Director, Global / Oncology Market Research at Bayer. His responsibilities include qualitative and
quantitative primary research, secondary research, forecasting and market size and structure analysis. In the past he has been on the Global
Market Research teams of Pfizer, Pharmacia, Searle, Roche Diagnostics and Boehringer Mannheim. Stuart has managed market research on
cancer treatment and prevention drugs, blood glucose monitors, point of care testing equipment and ophthalmic instruments. Stuart earned
his undergraduate degree from Lafayette College and achieved a Masters and PhD in Industrial/Organizational Psychology at Virginia Tech.
He currently resides in Central New Jersey with his wife Randi and children, Max and Dena.
_______________________________________________________________________________________________________________
|
| |
|
Lisa Griffith
Associate Director, Market Research
Ironwood Pharmaceuticals
_______________________________________________________________________________________________________________
|
|
|
|
Ames Gross
President and founder
Pacific Bridge Medical
Mr. Gross is recognized nationally and internationally as a leader in the Asian medical markets. In 2008, Medical Device and Diagnostic
Industry (MD&DI) magazine named Mr. Gross one of the top 100 executives in the medical business. Mr. Gross founded PBM in 1988 and has
helped hundreds of medical companies with business development and regulatory issues in Asia . Mr. Gross is a frequent contributor of
articles on Asian medical issues for Clinica ( England ), MD&DI ( Los Angeles ), and other medically oriented journals. Mr. Gross has been a
featured speaker on the Asian medical markets at the Medical Design and Manufacturing (MD&M) shows, the Medtrade Home Health Care
Exhibition, the Regulatory Affairs Professional Society’s annual and regional meetings, and a variety of other medically oriented meetings and
conferences. Mr. Gross has a BA degree, Phi Beta Kappa, from the University of Pennsylvania and an MBA from Columbia University .
_______________________________________________________________________________________________________________
|
|
|
|
George Grubb
Principal/Owner
G&S Research, Inc.
George Grubb is a founder of G & S Research (www.gs-research.com), a global healthcare primary market research company based out of
Indianapolis, IN. Since its inception in 1997, G & S has worked with over 130 bio-pharmaceutical, medical device, and diagnostic companies
to provide difference-making results.
G & S Research is a multiple recipient of the “Best Places to Work in Indiana” award, as well as a finalist in the Wall Street Journal’s national
“Top Small Workplaces” award, given to companies with the most exemplary, innovative workplaces.
As a principal, Mr. Grubb focuses on corporate strategy, business development, and professional relations for G & S Research and its
business units. Previous to starting the company, Mr. Grubb worked at Eli Lilly where he had responsibilities in new product planning, global
brand management, market research, and sales. Most of his Lilly tenure involved the Prozac® franchise, the company’s top-selling product at
the time.
Mr. Grubb received his undergraduate degree, as well as his MBA, from Indiana University’s Kelley School of Business in Bloomington, IN.
Between degrees, he worked for the Black and Decker Corporation. He is a regular speaker on market research issues, having spoken at the
PMRG, AMA, Indiana University and Indiana University-Purdue University (IUPUI).
_______________________________________________________________________________________________________________
|
|
|
|
Barbara Haimowitz
Associate Director, Market Research & Planning
Regeneron Pharmaceuticals, Inc.
Barbara Haimowitz is Associate Director, Market Research & Planning, at Regeneron Pharmaceuticals, Inc. In this capacity, she leads all
market research activities, ranging from early discovery and new product assessments to Phase 3 and in-line market research.
Barbara emphasizes the importance of creating a vision for brand development with attainable milestone achievements along the way. She is
a strong advocate for developing insightful business partnerships, specifically, with preclinical and clinical scientists. She enjoys New Product
Planning, as this provides a good opportunity for creative, strategic and longer-term thinking, in collaboration with large stakeholder teams.
Barbara holds a PhD from Tufts University in Experimental Psychology, and a Masters degree from Utrecht University in the Netherlands in
Clinical Psychology. She is on the Board of Directors of the Healthcare Businesswomen's Association (HBA) Metro Chapter, as Director of
Marketing.
_______________________________________________________________________________________________________________
|
| |
|
Ann Hale
Senior Director/Team Leader
Pfizer
_______________________________________________________________________________________________________________
|
| |
|
Thomas Han
Vice President US Marketing
Biovail
Mr. Han has over sixteen years of successful pharmaceutical industry experience including in-depth
experience within strategic marketing, pre-launch commercialization, product launches, brand marketing
and field sales.
Mr. Han started his pharmaceutical career in field sales and was successfully promoted to positions within
sales operations and marketing at Bristol-Myers Squibb. He then moved into marketing roles at both
Novartis and Schering-Plough. Mr. Han has had the opportunity to hold leadership roles on both small and
blockbuster brands.
In his current role, he is responsible for leading the product candidate identification and commercial
assessment process for Biovail. This includes forecast development and market research to validate and
quantify the risks associated with each opportunity across multiple therapeutic areas.
_______________________________________________________________________________________________________________
|
|
|
|
Matthew Handel
Sr. Director, Global Business Analysis & Forecasting
Shire
Matt Handel is Sr. Director of Business Analysis & Forecasting at Shire Pharmaceuticals. In this role, he leads a global team that provides
revenue forecasts and market analytics for all of Shire’s in-line and developmental. Matt also sits on Shire’s Government Relations committee
and is a leader of the Shire PAC.
During his four years at Shire, Matt has also been the U.S. Product General Manager for Fosrenol, Shire’s phosphate binder for patients with
chronic kidney disease, and was Sr. Director, Strategic Decision Support within the Global Product Management & Strategic Planning group.
Prior to working at Shire, Matt held a variety of sales, marketing, and market research positions at Merck in a number of therapeutic areas. For
several years, Matt was a Group Account Director at Pharmedica Communications, LLC. Matt received a B.A. from Princeton University and an
M.S. from the Sloan School of Management at the Massachusetts Institute of Technology.
_______________________________________________________________________________________________________________
|
| |
|
Glenn McAnanama
Associate Director, Market Research
Forest Laboratories
_______________________________________________________________________________________________________________
|
| |
|
Glen Misek
Director, Marketing Analytics and Business Insights
Abbott
_______________________________________________________________________________________________________________
|
| |
|
Anindita Niyogi
Director, Specialty Care Market Analytics
Pfizer Inc.
_______________________________________________________________________________________________________________
|
|
|
|
Marjorie Norman
Director, Worldwide Competitive Intelligence
Pfizer
Marjorie G. Norman is a Director, Worldwide Competitive Intelligence at Pfizer, specializing in providing business and competitive intelligence
to senior R&D management. Prior to joining Pfizer in 2002, she was Director –Pharmaceutical Practice, at Fuld & Company, a competitive
intelligence consulting firm and a Senior Market Research Analyst at Johnson & Johnson Professional. Ms. Norman holds an MBA from the
Graduate School of Management at Simmons College and a BA in German and art history from Franklin & Marshall College. She recently
returned from a six-month deployment at Population Services International in Nairobi, Kenya, as part of the Pfizer Global Health Fellows
program.
_______________________________________________________________________________________________________________
|
|
|
|
Scott D. Packard, PhD
Senior Vice President, Research
MedPanel
Scott D. Packard oversees quantitative product development and all quantitative research projects for MedPanel. Prior to joining the company,
Mr. Packard served as a Director at the Advisory Board Company in Washington, DC. While with the Advisory Board, he authored syndicated
research studies and helped launch and manage a clinical technology evaluation program. Mr. Packard holds his doctorate from the
Harvard-MIT Division of Health Sciences and Technology, a joint program between MIT and Harvard Medical School, following an
undergraduate degree in physics from Cornell University.
_______________________________________________________________________________________________________________
|
| |
|
Patricia Phillips
Manager Market Research
Daiichi Sankyo
_______________________________________________________________________________________________________________
|
| |
|
Grace Samoil Reynolds
Sr Director Global Strategic Analytics
Johnson & Johnson
Grace joined Johnson & Johnson in 1997 in the Market Research Department at Personal Products (consumer). She then progressed through
roles in Market Research and Forecasting management in the Pharmaceutical Sector, including responsibility for Women’s Health, Urology
and Pain at Ortho McNeil. Most recently, she is responsible for Market Research and Forecasting for the CNS and Pain Franchises in early
Pharmaceutical Development. She also has experience in Oncology, Anemia, Metabolics, and Mens Health. Prior to J&J, Grace worked at
Schering Plough and Colgate Palmolive, primarily in a Market Research capacity.
Grace earned her MBA at Rutgers University in New Jersey and holds a Bachelors in Chemistry from McGill University, Montreal, Canada. Her
passion is driving innovation and future thinking.
_______________________________________________________________________________________________________________
|
|
|
|
Geoffrey Scott
Senior Manager, Quantitative Commercial Insights
AstraZeneca
Geoff Scott is the Senior Manager, Quantitative Commercial Insights for the CRESTOR and CERTRIAD Dyslipidemia Franchises within the
Cardiovascular Portfolio Group at AstraZeneca. He has been with AstraZeneca for five years and manages marketing analytics and insights
activities for Astrazeneca’s dyslipidemia products as well as several related joint commercialization engagements.
Geoff’s interests and responsibilities fall broadly in the following marketing analytics areas: segmentation and targeting, product promotion-
response modeling, promotions-mix modeling, ROI analyses for both campaign and channel-level promotions to both physicians and
consumers, analytics to support market research survey development, fielding, and analysis, sales force sizing and structuring, call planning,
sample optimization, promotional SOV expansion, managed markets analytics, and analytic methodology and data cube development to
support promotional messaging platforms.
Prior to joining AstraZeneca, Geoff held numerous positions within the pharmaceutical and telecom industries, including Project Leader at
marketRx and Member of Technical Staff at Bell Labs, as well as a university adjunct professor, teaching undergraduate and graduate courses
in the area of management sciences. He is the author of more than fifty publications and presentations and is a member of a number of
pharma and management sciences-related industry groups.
Geoff has worked on various domestic and international assignments including projects in France, Germany, Spain, Mexico, People’s
Republic of China, and Republic of China. A native of New Jersey, he and his family currently reside in PA.
_______________________________________________________________________________________________________________
|
|
|
|
Sanjiv Sharma
Vice-President of Commercial Affairs
Nicox
Sanjiv Sharma has successful experience both at National and Global levels in Pharmaceutical Marketing, Sales Management, Strategic
Planning, Market Access, and Government Affairs. He has a sound knowledge of pharmaceutical markets and healthcare systems in both
North American and Asia. Currently, as a VP Commercial Affairs, He heads the commercial operations for NicOx SA and He is responsible for
implementing a global commercial strategy for NicOx’ portfolio and defining and implementing the strategy for establishing sales and
marketing operations in preparation for the launch of naproxcinod, the first compound in the CINOD class and the Company’s lead product for
the treatment of the signs and symptoms of osteoarthritis. Sanjiv is also heads NicOx’s US operations and is a member of the Company’s
Executive Committee. Before joining NicOx, He was head of Strategic Marketing & Business Analysis (SMBA) function for Biovail
Pharmaceutical Inc, USA. In this role, he was responsible for new product commercialization and strategic life cycle management across
five therapeutic areas with a special focus on Wellbutrin XL and Ultram ER franchise: marketing of the current legacy product portfolio.
Before joining Biovail, he worked for Sanofi-Aventis and its predecessor companies for 15 years. During these 15 years, he experienced the
success of several companies’ key brands through various commercial roles, e.g. Cardizem, Lovenox, Altace, Texotare, Amaryl, Lantus and
Exubera.
In the Global Marketing role in USA, He led several global cross-functional teams, in a matrix organization involving R&D, business
development, brand teams for USA, Japan and EU. Actively involved or led several strategic endeavors, e.g., Roadmap for Aventis Diabetes
leadership; Non injectable insulins strategy: North American Leadership Strategy; Aventis first Global Dynamic Diabetes Market Model for
strategic planning and forecasting multiple opportunities, and was also involved in several major Business Development deals and
partnerships.
At Aventis Canada, He was a member of the Management Committee (PMC) .Led three functional departments within commercial affairs and
led or involved in five products launches.
For his contribution in building innovative healthcare solutions, he was awarded “ The Year 2000 Who’s Who in Healthcare” by Rogers Media,
the largest healthcare publishing group in Canada. He holds MBA with Distinction from Richard Ivey School of Business, University of Western
Ontario, Canada, and was designated as an Ivey Scholar for Scholastic Excellence.
_______________________________________________________________________________________________________________
|
| |
|
Sanjaya Shunglu
Director, Market Research
Bristol Myers Squibb Co
_______________________________________________________________________________________________________________
|
|
|
|
Peter Simpson
Principal
Segmedica
Thirty five years of business experience have taken Peter all over the globe. He has lived and worked in the US, UK and Belgium. He has
operated in most of the world's major markets, including Japan and all of Europe. Most of his career has been spent in the Specialty Chemical,
Pharmaceutical, Medical Device and Biotechnology areas. His experiences have included the General Management of major businesses, CFO
of several companies, Strategic Planning Executive for businesses up to $2.5BN of revenue, as well as acquisitions and divestments, all
within the precursor units of AstraZeneca. He is a member of the Royal Institute of Chartered Management Accountants.
He has been Director of Marketing at Life Technologies Inc., a global supplier to the Biotechnology and Biopharmaceutical industry and Vice
President of Consulting and Market Research at Lowe Healthcare, one of the world's largest medical advertising agencies.
His client experience includes AstraZeneca, Schering Plough, Johnson and Johnson, TAP Pharmaceuticals, Boston Scientific, C R Bard,
Pfizer, Merck and many more leading companies. He has also worked with HMO's, Hospitals and Physicians' Practices.
Peter’s skills include strategic planning processes, branding issues, healthcare marketing and innovative market research. In over a decade
of consulting with the healthcare industry he has conducted numerous research projects of all types and is an experienced interviewer and
facilitator. He has been researching and developing psychology based methodologies for medical market research for seven years and has
developed a number of novel techniques and processes.
_______________________________________________________________________________________________________________
|
|
|
|
Paul Snyderman
Chief Research Officer
Ipsos Health
As Chief Research Officer for Ipsos Health, Dr. Snyderman is responsible for all aspects of innovative methodological development and
market research approaches as well as consulting directly with client’s on their most critical business issues.
Dr. Snyderman’s previous role was as Executive Director and Technical Advisor in Global Customer Insights at Merck. In this role he is
responsible for establishing and maintaining best practices in both primary and secondary market research. Prior to taking these
responsibilities, Paul directed the market research efforts for the oncology and ophthalmology franchises as well as for New Products.
Paul has been at Merck for 23 years. While taking positions of increasing responsibility, Paul has directed activities that have included the pre-
launch primary and secondary market research for: Pepcid, Prinivil, Prilosec, Zocor, MMR-II, PedVax-HIB, Cozaar, Proscar, Fosamax, Crixivan,
Aggrastat, Invanz, Cancidas and Zetia.
Paul received his B.A. in Psychology and Ph.D. in Social Psychology from Temple University. He began his career in market research with the
National Analysts Division of Booz, Allen and Hamilton.
_______________________________________________________________________________________________________________
|
|
|
|
Seenu Srinivasan
Adams Distinguished Professor of Management
Stanford Business School
Professor Srinivasan’s primary research interest is in the measurement of customer preferences (conjoint analysis). He has also contributed
to other market research areas such as new product development, market structuring, and the measurement of brand equity. At the Stanford
MBA program he teaches an elective, “Customer-Focused Product Marketing.” He received the Parlin Award for outstanding contributions to
marketing research, the Churchill Award for lifetime achievement in marketing research, the Converse Award for outstanding contributions to
the development of the science of marketing, and ten other best research paper awards.
Professor V. “Seenu” Srinivasan received his Bachelor’s degree in Mechanical Engineering from the Indian Institute of Technology, Madras
(Chennai), and was the gold medalist in his graduating class. He received his Ph.D. in Industrial Administration from Carnegie-Mellon
University. He is currently the Adams Distinguished Professor of Management at the Stanford Business School. He was formerly the director of
the doctoral program.
_______________________________________________________________________________________________________________
|
|
|
|
R. Sukumar
President
Optimal Strategix Group
Dr. Sukumar is President of Optimal Strategix Group. He works with clients to provide strategic guidance and has assisted with developing
research methodologies to solve their different problems. He has spent over 25 years in academia, and has worked with various global
corporations. Sukumar taught Marketing Strategy and Marketing Research in MBA and Executive MBA programs in top U.S. academic
institutions including Rutgers Business School, Thunderbird, Garvin School of International Management, the Smith School of Business at the
Univ. of Maryland, Bauer College of Business, Univ. of Houston; Jones School of Management, Rice University, and Univ. of Georgia; Terry
College of Business. He was Associate Dean at the Indian School of Business.
During the span of his academic career, Dr. Sukumar provided consulting services to companies in the Consumer Packaged Goods, Financial
Services, Hospitality and Pharmaceutical industries. He has worked with market research firms such as The NPD Group, and IPSOS. He also
co-founded two companies in the area of software development and marketing consulting.
Dr. Sukumar completed his MBA and Ph.D. from the University of Pittsburgh in Marketing and Business Administration. His undergraduate
degree is in Mechanical Engineering from the Indian Institute of Technology in India.
_______________________________________________________________________________________________________________
|
|
|
|
Erico von Bueren
Global Product Marketing Manager
Thermo Fisher Scientific
Erico von Bueren obtained his Medical Degree (MD) from the University of Essen, the PhD from the University of Frankfurt, and his Master of
Operations Research (MOR) from the University of Aachen, Germany. He has worked as a medical advisor and product manager for two
pharmaceutical companies and two companies in diagnostics. He joined Thermo Fisher Scientific in 2008, presently working as the global
product and marketing manager responsible for IHC in the Anatomical Pathology Division out of Kalamazoo , Michigan .
_______________________________________________________________________________________________________________
|
| |
|
|
|
